Institutions Holding Call Options on Celldex Therapeutics, Inc. (CLDX)
This table provides information about the call option holders of Celldex Therapeutics, Inc. (CLDX). We have compiled data on the institutions that hold call options on the stock, with a total of 959,904 call options outstanding, which have been reported (via 13F filing form) to have a value of $18.6 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Caption Management, LLC
Oklahoma City, OK |
Feb 14, 2025 Q4 2024 |
373,000
calls
|
$7.46 Million
0.1% of portfolio
|
Q4 2024
Added 6.57%
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
127,700
calls
|
$2.55 Million
0.04% of portfolio
|
N/A
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
103,500
calls
|
$2.07 Million
0.0% of portfolio
|
N/A
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
101,800
calls
|
$2.04 Million
0.0% of portfolio
|
N/A
|
|
Diadema Partners LP
Morristown, NJ |
Feb 14, 2025 Q4 2024 |
100,000
calls
|
$2 Million
1.08% of portfolio
|
Q4 2024
New holding
|
|
Wells Fargo & Company
San Francisco, CA |
Feb 12, 2025 Q4 2024 |
68,900
calls
|
$1.38 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
49,000
calls
|
$980,000
0.0% of portfolio
|
N/A
|
|
J. Goldman & CO LP
New York, NY |
Feb 14, 2025 Q4 2024 |
20,300
calls
|
$406,000
0.01% of portfolio
|
Q4 2024
New holding
|
|
Wolverine Trading, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
10,200
calls
|
$204,000
0.0% of portfolio
|
Q4 2024
Reduced 22.14%
|
|
Torno Capital, LLC
Cohasset, MA |
Feb 14, 2025 Q4 2024 |
5,300
calls
|
$106,000
0.01% of portfolio
|
Q3 2024
New holding
|
|
Persistent Asset Partners LTD
Hong Kong, K3 |
Feb 14, 2025 Q4 2024 |
204
calls
|
$4,080
0.01% of portfolio
|
Q4 2024
New holding
|